Abstract
Background The right to left ventricular diameter ratio (RV/LV) is a key imaging parameter used in risk stratification of pulmonary embolism. While having RV/LV above a cutoff value of 0.9 is usually attributed to pathological RV dilatation, we hypothesized that increased RV/LV may also be attributable to reduced LV filling. We aimed to examine RV and LV diameters as independent predictors of PE outcomes in patients presenting with intermediate or high-risk PE.
Methods We measured RV and LV diameters on pre-intervention echocardiograms performed on 164 subjects presenting at or referred to our center for large PE requiring surgical thrombectomy, venoarterial extracorporeal membrane oxygenation (VA-ECMO), or catheter directed thrombectomy.
Results The primary outcome of death (n=3) or survival of cardiopulmonary resuscitation (CPR) (n=11) was met in 14 subjects. Smaller LV diameter and larger RV diameter were each demonstrated to be independent predictors of the primary outcome. LV diameter of <3.6 cm, RV diameter >5.0 cm, and RV/LV ratio of >1.2 were the cutoff values for each parameter most associated with the primary outcome.
Conclusion This study demonstrates that, in addition to dilated RV, small LV is an independent risk factor of death or need for CPR in hemodynamically significant PE treated with advanced therapies. This finding suggests that the predictive value of RV/LV for PE outcomes may be attributed to both RV enlargement and reduced LV filling.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of New York Medical College/Westchester Medical Center approved this study under the 'consent exempt' category.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article [and/or] its supplementary materials.